Waterloo Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Waterloo Capital's VRTX Position: Q2 2026 in Review
Waterloo Capital increased its Vertex Pharmaceuticals (VRTX) stake by 19% in Q2 2026, buying an estimated $258K and bringing the position to 3,651 shares worth $1.81M. The position accounts for 0.1% of the portfolio, ranked #185.
Waterloo Capital first reported a position in VRTX in Q2 2024 and has held it in 5 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Waterloo Capital held 3,651 shares of Vertex Pharmaceuticals worth $1.81M as of Q2 2026.
- Waterloo Capital bought 583 Vertex Pharmaceuticals shares in Q2 2026, an estimated $258K.
- Vertex Pharmaceuticals made up 0.1% of Waterloo Capital's portfolio in Q2 2026, its #185 holding.
- Waterloo Capital first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 5 quarters since.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Waterloo Capital's 13F filing for Q2 2026, filed 29 Jul 2026.